Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.58
+1.91 (6.03%)
At close: Apr 2, 2026, 4:00 PM EDT
33.08
-0.50 (-1.49%)
After-hours: Apr 2, 2026, 7:42 PM EDT
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
n/a
Profits / Employee
-$1,327,179
Market Cap
1.61B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Nuvation Bio | 298 |
| Biohaven | 274 |
| Maze Therapeutics | 141 |
| MBX Biosciences | 63 |
RAPP News
- 3 days ago - Neuphonic and Rapport Bring Real-Time Digital Humans to Everyday Hardware - Business Wire
- 3 days ago - Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting - GlobeNewsWire
- 5 days ago - CRCAM Toulouse 31 - Rapport financier annuel 2025 - GlobeNewsWire
- 17 days ago - Rapport Therapeutics, Inc. (RAPP) Presents at Stifel 2026 Virtual CNS Forum Transcript - Seeking Alpha
- 23 days ago - Mise à disposition des éléments préparatoires à l'AG du 27/03/2026 - Rapport Financier Annuel 2025 - GlobeNewsWire
- 25 days ago - Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 26 days ago - Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China - GlobeNewsWire
- 5 weeks ago - Rapport Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire